Clinical Trial Update: Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating changes in skin autofluorescence after weight loss and maintenance with liraglutide in knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis Knee

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Parker Research Institute | Conditions: Osteoarthritis, Knee | Phase 4 | Status: COMPLETED